Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[<sup>68</sup>Ga]Ga-PSMA-11 PET/CT for baseline staging of high-risk prostate cancer: A real-world study.

BJUI compass·2026
Same author

Does <sup>18</sup>F-sodium fluoride PET/CT have a role in the assessment of response to <sup>223</sup>Ra therapy in men with prostatic bone metastases?

European journal of nuclear medicine and molecular imaging·2026
Same author

Imaging xCT with Immuno-PET in Therapy-Resistant Non-Small Cell Lung Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

LuRa: Efficacy and Safety of Radium-223 Following [<sup>177</sup>Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer.

Clinical genitourinary cancer·2026
Same author

Diagnostic Accuracy of [<sup>68</sup>Ga]Ga-PSMA-11 PET-CT in Characterising Bone Lesions in Prostate Cancer: A Single-Centre Study.

Cancers·2026
Same author

Independent Testing of Published CT Models for PD-L1 Status in Non-Small Cell Lung Cancer.

Radiology·2026
Same journal

Present and Emerging Strategies for Disease Assessment in Hodgkin Lymphoma.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Nodular Lymphocyte-predominant Hodgkin Lymphoma: Incidence, Pathogenesis, Management.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Management of Classic Hodgkin Lymphoma in Special Clinical Situations.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Older Patients With Hodgkin Lymphoma: A Contemporary Review.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Adolescent and Young Adult Patients With Classical Hodgkin Lymphoma: A Review as a Case Study in AYA Cancer Care.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Hodgkin Lymphoma: Management of Patients Who Fail Primary Therapy.

Cancer journal (Sudbury, Mass.)·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2025

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.7K

Bone Metastases.

Gary J R Cook1, Matthew P Thorpe2

  • 1From the Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, St. Thomas' Hospital, London, UK.

Cancer Journal (Sudbury, Mass.)
|May 16, 2024
PubMed
Summary
This summary is machine-generated.

Early detection and monitoring of bone metastases from cancers like breast and prostate are crucial. Advanced molecular imaging agents aid in identifying metastases and assessing treatment effectiveness, including radionuclide therapies.

More Related Videos

Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.1K
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

4.8K

Related Experiment Videos

Last Updated: Jun 26, 2025

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.7K
Models of Bone Metastasis
08:49

Models of Bone Metastasis

Published on: September 4, 2012

42.1K
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

4.8K

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiology

Background:

  • Bone metastases are common in breast and prostate cancer, causing significant morbidity and skeletal-related events.
  • Effective management requires early detection and accurate monitoring of treatment response.

Purpose of the Study:

  • To highlight the importance of early detection and monitoring of bone metastases.
  • To review the role of molecular imaging agents in managing bone metastases and guiding therapy.

Main Methods:

  • Review of current diagnostic and therapeutic strategies for bone metastases.
  • Discussion of single-photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging agents.
  • Exploration of theranostic agents for predicting radionuclide therapy response.

Main Results:

  • Molecular imaging agents enable sensitive detection of bone metastases.
  • These agents assist in monitoring response to systemic therapies.
  • Theranostic agents can confirm target expression and predict treatment outcomes.

Conclusions:

  • Early and accurate imaging of bone metastases is vital for patient care.
  • Molecular imaging plays a key role in optimizing cancer treatment strategies.
  • Theranostic approaches hold promise for personalized radionuclide therapy in bone metastases.